Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420172 · ClinicalTrials.gov registry record
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
A clinical trial of Post Hematopoietic Stem Cell Transplantation, sponsored by Karen Wood.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT01420172 is a study of Post Hematopoietic Stem Cell Transplantation that has completed, run by Karen Wood. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01420172, a study of Post Hematopoietic Stem Cell Transplantation, has completed, sponsored by Karen Wood.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011. This study will determine factors influencing pulmonary disease and associated treatment strategies.
Conditions Studied
Interventions
- OTHER Data Collection
Study Locations (1)
Ohio
- The Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-07-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420172
The ClinicalTrials.gov registry entry for NCT01420172 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karen Wood, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.
NCT01420172 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01420172 about?
NCT01420172 is a clinical study titled "Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation". This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011. This study will determine factors influencing pulmonary disease and associated tr...
What is the current status of trial NCT01420172?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2011-08. Estimated completion is 2016-07-08.
What conditions does trial NCT01420172 study?
This clinical trial studies the following conditions: Post Hematopoietic Stem Cell Transplantation.
What interventions are being tested in trial NCT01420172?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT01420172?
This trial is sponsored by Karen Wood, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01420172 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Hematopoietic Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.